Cardioselective Beta-Blockers in Patients with Asthma and Concomitant Heart Failure or History of Myocardial Infarction: When Do Benefits Outweigh Risks?

Journal of Asthma

Volumn 40, Issue 8, 2003, Pages 839-845

  Self, Timothy H ^a   Soberman, Judith E ^a   Bubla, Jamie M ^a   Chafin, Carol C ^b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BEVANTOLOL; CARVEDILOL; IPRATROPIUM BROMIDE PLUS SALBUTAMOL SULFATE; METOPROLOL; PRACTOLOL;

ASTHMA; BRONCHOSPASM; CARDIOSELECTIVITY; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DISEASE EXACERBATION; DOSE RESPONSE; DRUG CHOICE; DRUG CONTRAINDICATION; DRUG EFFECT; DRUG INDICATION; DRUG RESPONSE; DRUG SAFETY; DRUG USE; HEART FAILURE; HEART INFARCTION; HOSPITALIZATION; HUMAN; IATROGENIC DISEASE; REVIEW; RISK BENEFIT ANALYSIS;

ADRENERGIC BETA-ANTAGONISTS; ASTHMA; BRONCHIAL SPASM; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART FAILURE, CONGESTIVE; HUMANS; MYOCARDIAL INFARCTION; SEVERITY OF ILLNESS INDEX;

EID: 0347356471     PISSN: 02770903     EISSN: None     Source Type: Journal    
DOI: 10.1081/JAS-120025582     Document Type: Review

References (73)

1. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996; 334:1349-1355.
2. The Australia-New Zealand Heart Failure Reseach Collaborative Group. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Lancet 1997; 349:375-380.
3. Lechat P, Packer M, Chalon S, Cucherat M, Arab T, Boissel JP. Clinical effects of beta adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials. Circulation 1998; 98:1184-1191.
4. CIBIS-II Investigators and Committees. The cardiac insufficiency bisoprolol study II (CIBIS-II): a randomised trial. Lancet 1999; 353:9-13.
5. Hjalmarson A, Goldstein S, Fagerberg B, Wedel H, Waagstein F, Kjekshus J, Wikstrand J, El Allaf D, Vitovec J, Aldershvile J, Halinen M, Dietz R, Neuhaus KL, Janosi A, Thorgeirsson G, Dunselman PH, Gullestad L, Kuch J, Herlitz J, Rickenbacher P, Ball S, Gottlieb S, Deedwania P. Effects of controlled-release metoprolol on total mortality, hospitalizations and well-being in patients with heart failure: the metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF). JAMA 2000; 283:1295-1302.
6. Heart Failure Society of America. HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction-pharmacological approaches. Pharmacotherapy 2000; 20:495-522.
7. Beta-Blocker Heart Attack Trial Research Group. A randomised trial of propranolol in patients with acute myocardial infarction Mortality results. JAMA 1982; 247:1707-1714.
8. The Norwegian Multicenter Study Group. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 1981; 304:801-807.
9. Hjalmarson A, Emfeldt D, Herlitz A, Holmberg S, Malek I, Nyberg G, Ryden L, Swedberg K, Vedin A, Waagstein F, Waldenstrom A, Waldenstrom J, Wedel H, Wilhelmsen L, Wilhelmsson C. Effect on mortality of metoprolol in acute myocardial infarction: a double-blind randomised trial. Lancet 1981; 2:823-827.
10. Committee on Management of Acute Myocardial Infarction. ACC/AHA guidelines for the management of patients with acute myocardial infarction. J Am Coll Cardiol 1996; 28:1328-1428.
11. Ellerbeck EF, Jencks SF, Radford MJ, Kresowik TF, Craig AS, Gold JA, Krumholz HM, Vogel RA. Quality of care for Medicare patients with acute myocardial infarction: a four-state pilot study from the Cooperative Cardiovascular Project. JAMA 1995; 273:1509-1514.
12. Brand DA, Newcomer LN, Freiburger A, Tian H. Cardiologists' practices compared with practice guidelines: use of beta-blockade after acute myocardial infarction. J Am Coll Cardiol 1995; 26:1423-1426.
13. Viskin S, Kitzis I, Lev E, Zak Z, Heller K, Villa Y, Zajarias A, Laniado S, Belhassen B. Treatment with beta-adrenergic blocking agents after myocardial infarction: from randomized trials to clinical practice. J Am Coll Cardiol 1995; 25:1327-1332.
14. Barron HV, Viskin S, Lundstrom RJ. Beta-blocker dosages and mortality after myocardial infarction. Arch Intern Med 1998; 158:449-453.
15. Gottlieb SS, McCarter RJ, Vogel RA. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med 1998; 339:489-497.
16. Krumholz HM, Radford MJ, Wang Y, Chen J, Heiat A, Marciniak TA. National use and effectiveness of beta blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project. JAMA 1998; 280:623-629.
17. Komajda M, Follath F, Swedberg K, Cleland J, Aguilar JC, Cohen-Solal A, Dietz R, Gavazzi A, Van Gilst WH, Hobbs R, Korewicki J, Madeira HC, Moiseyev VS, Preda I, Widimsky J, Free-mantle N, Eastaugh J, Mason J. The EuroHeart failure survey programme-a survey on the quality of care among patients with heart failure in Europe Part 2: treatment. Eur Heart J 2003; 24:464-474.
18. McNeill RS. Effect of a beta adrenergic blocking agent, propranolol, on asthmatics. Lancet 1964; 2:1101-1102.
19. McNeill RS, Ingram CG. Effect of propranolol on ventilatory function. Am J Cardiol 1966; 18:473-475.
20. Raine JM, Palazzo MG, Kerr JH, Sleight P. Near fatal bronchospasm after oral nadolol in a young asthmatic and response to ventilation with halthane. BMJ 1981; 282:548-549.
21. Williams IP, Millard FJC. Severe asthma after inadvertent ingestion of oxprenolol. Thorax 1980; 35:160.
22. Harries AD. Beta blockade in asthma. BMJ 1981; 282:1321.
23. Fraunfelder FT, Barker AF. Respiratory effects of timolol. N Engl J Med 1984; 311:1441.
24. Odeh M, Oliven A, Bassan H. Timolol eyedrop-induced fatal bronchospasm in an asthmatic patient. J Fam Pract 1991; 32:97-98.
25. Wilcox PG, Ahmad D, Darke AC, Parsons J, Carruthers SG. Respiratory and cardiac effects of metoprolol and bevantolol in patients with asthma. Clin Pharmacol Ther 1986; 39:29-34.
26. Ellis ME, Sahah JN, Chatterjee SS, Cruickshank JM, Ellis SH. Cardioselectivity of atenolol in asthmatic patients. Eur J Clin Pharmacol 1981; 21:173-176.
27. Clague H, Ahmad D, Carruthers SG. Influence of cardioselectivity and respiratory disease on pulmonary responsiveness to beta blockade. Eur J Clin Pharmacol 1984; 27:517-523.
28. Salpeter SR, Ormiston TM, Salpeter EE. Cardio-selective beta blockers in patients with reactive airway disease: a meta-analysis. Ann Intern Med 2002; 137:715-725.
29. Epstein PE. Fresh air and beta blockade. Ann Intern Med 2002; 137:766-767.
30. Chafin CC, Soberman JE, Demirkan K, Self T. Beta-blockers after myocardial infarction: do benefits ever outweigh risks in asthma. Cardiology 1999; 92:99-105.
31. Nicolaescu V, Manivadite M, Stroescu V. Beta adrenergic blockade with practolol in acetylcholine-sensitive asthma patients. Respiration 1972; 29:139-154.
32. Nicolaescu V, Racoveanu C, Manicatide M. Effects of exercise on practolol-treated asthmatic patients. Eur J Clin Pharmacol 1973; 6:3-8.
33. Johnsson G, Svedmyr N, Thiringer G. Effects of intravenous propranolol and metoprolol and their interaction with isoprenaline on pulmonary function, heart rate, and blood pressure in asthmatics. Eur J Clin Pharmacol 1975; 8:175-180.
34. Skinner C, Palmer KN. Comparison of the effects of acebutolol and practolol on airways obstruction in asthmatics. Br J Clin Pharmacol 1978; 5:415-419.
35. Benson MK, Berrill WT, Cruickshank JM, Sterling GS. A comparison of four beta adrenoceptor antagonists in patients with asthma. Br J Clin Pharmacol 1978; 5:415-419.
36. Ruffin RE, Frith PA, Anderton RC, Kumana CR, Newhouse MT, Hargreave FE. Selectivity of beta adrenoreceptor antagonist drugs assessed by histamine bronchial provocation. Clin Pharmacol Ther 1979; 25:536-540.
37. Lofdahl CG, Svedmyr N. Cardioselectivity of atenolol and metoprolol: a study in asthmatic patients. Eur J Respir Dis 1981; 62:396-404.
38. Van den Bergh JH, van Herwaarden CL. Ventilatory effects of ordinary and slow-release tablets of metoprolol in asthmatic patients. Eur J Respir Dis 1981; 62:168-172.
39. Lawrence DS, Sahay JN, Chatterjee SS, Cruickshank JM. Asthma and beta blockers. Eur J Clin Pharmacol 1982; 22:501-509.
40. Greefhorst AP, van Herwaarden CL. Ventilatory and haemodynamic effects of beta 1-selective and beta 2-selective stimulation in asthmatic patients. Eur J Respir Dis., Suppl 1984; 135:147-150.
41. 1-receptor-selective blockade with bisoprolol and metoprolol in asthmatic patients. Eur J Clin Pharmacol 1984; 27:141-145.
42. Doshan HD, Rosenthal RR, Brown R, Slutsky A, Applin WJ, Caruso FS. Celiprolol, atenolol and propranolol: a comparison of pulmonary effects in asthmatic patients. J Cardiovasc Pharmacol 1986; 8(Suppl 4):S105-S108.
43. Doshan HD, Brown R, Applin WJ, Kapoor M, Caruso FS. Effects of high doses of celiprolol in asthmatic patients. J Cardiovasc Pharmacol 1986; 8(Suppl 4):S109-S111.
44. Chatterjee SS. The cardioselective and hypotensive effects of bisoprolol in hypertensive asthmatics. J Cardiovasc Pharmacol 1986; 8(Suppl 11):S74-S77.
45. Lammers JW, Muller ME, Folgering HT, van Herwaarden CL. A comparative study on the ventilatory and haemodynamic effects xamoterol and atenolol in asthmatic patients. Br J Clin Pharmacol 1986; 22:595-602.
46. Falliers CJ, Vincent ME, Medakovic M. Effect of single doses of labetalol, metoprolol, and placebo on ventilatory function in patients with bronchial asthma: interaction with isoproterenol. J Asthma 1986; 23:251-260.
47. Chodosh S, Tuck J, Blasucci DJ. The effects of dilevalol, metoprolol, and placebo on ventilatory function in asthmatics. J Cardiovasc Pharmacol 1988; 11(Suppl 2): S18-S24.
48. Lammers JW, Muller ME, Folgering HT, van Herwaarden CL. Effects of terbutaline and atenolol on large and small airways in asthmatic patients. Eur Respir J 1988; 1:453-457.
49. Fogari R, Zoppi A, Tettamanti F, Poletti L, Rizzardi, Fiocchi G. Comparative effects of celiprolol, propranolol, oxprenolol, and atenolol on respiratory function in hypertensive patients with chronic obstructive pulmonary disease. Cardiovasc Drugs Ther 1990; 4:1145-1149.
50. Tantucci C, Bruni B, Dottorini ML, Peccini F, Motolese M, Lecaillon JB, Sorbini CA, Grassi V. Comparative evaluation of cardioselectivity of metoprolol OROS and atenolol: a double-blind, placebo-controlled crossover study. Am Heart J 1990; 120:467-472.
51. Plosker GL, Clissold SP. Controlled release metoprolol formulations. Drugs 1992; 43:382-414.
52. Decalmer PB.S, Chatterjee SS, Cruickshank JM, Benson MK, Sterling GM. Beta blockers and asthma. Br Heart J 1978; 40:184-189.
53. van Zyl AI, Jennings AA, Bateman ED, Oie LH. Comparison of respiratory effects of two cardio-selective beta blockers, celiprolol and atenolol, in asthmatics with mild to moderate hypertension. Chest 1989; 95:209-213.
54. Formgren H. The effect of metoprolol and practolol on lung function and blood pressure in hypertensive asthmatics. Br J Clin Pharmacol 1976; 3:1007-1014.
55. Klein L, O'Connor CM, Gattis WA, Zampino M, de Luca L, Vitarelli A, Fedele F, Gheorghiade M. Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations. Am J Cardiol 2003; 91(Suppl 9A):18F-40F.
56. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF). Lancet 1999; 353:9-13.
57. Wikstrand J, Hjalmarson A, Waagstein F, Fagerberg B, Goldstein S, Kjekshus J, Wedel H. Dose of metoprolol CR/XL and clinical outcomes in patients with heart failure: analysis of the experience in metoprolol CR/XL randomized intervention trial in chronic heart failure (MERIT-HF). J Am Coll Cardiol 2002; 7:491-498.
58. Kotlyar E, Keogh AM, Macdonald PS, Arnold RH, McCaffrey DJ, Glanvile AR. Tolerability of carvedilol in patients with heart failure and concomitant chronic obstructive pulmonary disease or asthma. J Heart Lung Transplant 2002; 21:1290-1295.
59. Frishman WH. Carvedilol. N Engl J Med 1998; 339:1759-1765.
60. Coreg (carvedilol) product literature. In Physicians' Desk Reference. 57th ed. Thomson PDR: Montavale, NJ, 2003:1491-1496.
61. Sturm B, Pacher R, Strametz-Juranek J, Berger R, Frey B, Stanek B. Effect of beta 1 blockade with atenolol on progression of heart failure in patients pretreated with high-dose enalapril. Eur J Heart Fail 2000; 2:407-412.
62. Hulsmann M, Sturm B, Pacher R, Berger R, Bojic A, Frey B, Stanek B. Long term effect of atenolol on ejection fraction, symptoms and exercise variables in patients with advanced left ventricular dysfunction. J Heart Lung Transplant 2001; 20:1174-1180.
63. Olsson G, Rehnqvist N, Sjogren A, Erhardt L, Lundman T. Long term treatment with metoprolol after myocardial infarction: effect on 3 year mortality and morbidity. J Am Coll Cardiol 1985; 5:1428-1437.
64. Wilcox RG, Roland JM, Banks DC, Hampton JR, Mitchell JR.A. Randomized trial comparing propranolol with atenolol in immediate treatment of suspected myocardial infarction. Br Med J 1980; 280:885-888.
65. Rochon PA, Tu JV, Anderson GM, Gurwitz JH, Clark JP, Lau P, Szalai JP, Sykora K, Naylor CD. Rate of heart failure and 1-year survival for older people receiving low-dose beta-blocker therapy after myocardial infarction. Lancet 2000; 356:639-644.
66. Expert Panel Report 2 Guidelines for the Diagnosis and Management of Asthma. National Institutes of Health: Bethesda, MD, 1997. NIH Publication No 97-4051.
67. Executive Summary of the NAEPP Expert Panel Report Guidelines for the Diagnosis and Management of Asthma-Update on Selected Topics 2002. National Institutes of Health: Bethesda, MD, 2002. NIH Publication No 02-5075.
68. 2 adrenoceptor polymorphism and susceptibility to bronchodilatory desensitization in moderately severe stable asthmatics. Lancet 1997; 350:995-999.
69. Krum H. Beta-blockers in chronic heart failure: what have we learned? What do we still need to know? Curr Opin Pharmacol 2003; 3:168-174.
70. Cockcroft DW. Management of acute severe asthma. Ann Allergy, Asthma, & Immun 1995; 75:83-89.
71. Ind PW, Dixon CM.S, Fuller RW, Barnes PJ. Anticholinergic blockade of beta-blocker-induced bronchoconstriction. Am Rev Respir Dis 1989; 139:1390-1394.
72. Giulekas D, Georgopoulos D, Papakosta D, Antoniadou H, Sotiropoulou E, Vamvalis C. Influence of pindolol on asthmatics and effect of bronchodilators. Respiration 1986; 50:158-166.
73. Bradley DJ, Bradley EA, Baughman KL, Berger RD, Calkins H, Goodman SN, Kass DA, Powe NR. Cardiac resynchronization and death from progressive heart failure, a meta-analysis of randomized controlled trials. JAMA 2003; 289:730-740.